Document Page: First | Prev | Next | All | Image | This Release | Search
File: 120396_sep96_decls31_0006.txt
Subject: RECOMMENDATIONS OF THE AD HOC WORKING GROUP
Unit: OTSG
Parent Organization: HSC
Box ID: BX003203
Folder Title: RECOMMENDATIONS OF THE AD HOC GROUP FOR THE MEDICAL DEFENSE AGAINST BIOLOGICAL WARFARE
Document Number: 1
Folder SEQ #: 175
4w U.S. ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND
BOTULINUM ANTITOXIN
(Horse Heptavalent FAB2 Fragment)
Use: Treatment of Botulinum Intoxications
FDA Status: IND
Dosage Schedule: TBD
Manufacturer: University of Minnesota (Conde)
Availability:
Doses: vials available by 5 Oct 90
Safety testing and dosage studies required
Earliest Use: 1 Dec 90
Comments: 1 000 liters of horse plasma is available for
processing
UNCLASSIFI
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 7 f:/Week-36/BX003203/RECOMMENDATIONS OF THE AD HOC GROUP FOR THE MEDICAL DEFENSE AGAINST BIOLOGICAL WARFARE/recommendations of the ad hoc working group:11089615091832
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = RECOMMENDATIONS OF THE AD HOC GROUP FOR THE MEDICAL DEFENSE AGAINST BIOLOGICAL WARFARE
Folder Seq # = 175
Subject = RECOMMENDATIONS OF THE AD HOC WORKING GROUP
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 08-NOV-1996